Vulvovaginal Candidiasis - Pipeline Insight, 2019 - ResearchAndMarkets.com

The "Vulvovaginal Candidiasis - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.

Vulvovaginal Candidiasis - Pipeline Insight, 2019 offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Vulvovaginal Candidiasis development.

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental Stages:

• Clinical
• Non-clinical
• Inactive: Discontinued and/or Dormant

Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Scope of the Report

• The report provides a snapshot of the pipeline development for the Vulvovaginal Candidiasis
• The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Vulvovaginal Candidiasis
• The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Vulvovaginal Candidiasis
• The report also covers the dormant and discontinued pipeline projects related to the Vulvovaginal Candidiasis

Topics Covered

1. Report Introduction

2. Vulvovaginal Candidiasis Overview

3. Pipeline Therapeutics

• An Overview of Pipeline Products for Vulvovaginal Candidiasis

4. Comparative Analysis

5. Products in Clinical Stage

5.1 Drug Name : Company Name

• Product Description
• Research and Development
• Product Development Activities

6. Products in Pre-Clinical and Discovery Stage

6.1 Drug Name : Company Name

• Product Description
• Research and Development
• Product Development Activities

7. Therapeutic Assessment

• Assessment by Route of Administration
• Assessment by Stage and Route of Administration
• Assessment by Molecule Type
• Assessment by Stage and Molecule Type

8. Inactive Products

8.1 Drug Name : Company Name

• Product Description
• Research and Development
• Product Development Activities

Companies Featured

• Allergan
• Cidara Therapeutics
  
• Ferrer International
  
• Mariposa Health
• Matinas BioPharma Nanotechnologies
  
• Merck & Co.
• Mirati Therapeutics
• NovaDigm Therapeutics
• Pharmacon-Forschung Und Beratung
• Scynexis
  
• Toltec Pharmaceuticals
• Viamet Pharmaceuticals
  
• Zengen

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/w6brxh/vulvovaginal?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190313005361/en/